Survival of a Rifampicin-Resistant Pseudomonas fluorescens

Pseudomonas fluorescens strain D7 (P.f. D7) is a naturally occurring soil bacterium that shows promise as a biological herbicide to inhibit growth of annual grass weeds, including downy brome (Bromus tectorum L.), in crop- and rangelands. Pseudomonas fluorescens strain D7rif (P.f. D7rif) is a rifampicin-resistant strain of P.f. D7. One of the greatest obstacles to successful biological weed control is survival of the organism under field conditions. Nine soils in the taxonomic order of Mollisols, collected from downy brome-infested areas of the Western and Central United States, were inoculated with P.f. D7rif and incubated in the laboratory to determine the effects of soil type, soil properties, incubation temperature, and soil water potential on survival of P.f. D7rif over 63 days. Silt loam soils from Lind, Washington, and Moro, Oregon, sustained the highest P.f. D7rif populations, and recovery was the lowest from Pendleton, Oregon soil. Survival and recovery of P.f. D7rif varied with soil type and temperature but not with the two soil water potentials tested. After 63 days, P.f. D7rif was recovered at levels greater than log 5.5 colony forming units (CFU) g−1 soil from five of the nine test soils, a level adequate to suppress downy brome under field or range conditions

Prediction of Canola Residue Characteristics Using Near-Infrared Spectroscopy

Little work has been done to characterize and quantify the residue traits affecting decomposition of winter and spring canola (Brassica napus L.) residue in dryland farming systems of the Pacific Northwest United States. Traditional methods of characterizing residue fiber and nutrients are time-consuming and expensive and require large quantities of chemical reagents. The goal of this research was to determine whether near-infrared spectroscopy (NIRS) could accurately predict neutral detergent fiber (NDF), acid detergent fiber (ADF), acid detergent lignin (ADL), carbon (C), and nitrogen (N) of canola stems, litter, and roots and decomposition of canola stems. Canola residue varied in decomposition, fiber, and nutrients by year, location, and type. NIRS predictions were successful for NDF and ADF in 2011 (standard error of prediction SEP<2.67; R2>0.95) and NDF, ADF, and N in 2012 (SEP<2.38; R2>0.91). Other predictions for residue fiber and nutrient characteristics were considered moderately successful. Prediction of canola residue decomposition with NIRS was useful for screening purposes. Near-infrared spectroscopy shows promise for rapidly and reproducibly predicting some canola residue fiber and nutrient traits and may be useful for estimating residue decomposition potential in dryland conservation cropping systems

Rapid Estimation of Wheat Straw Decomposition Constituents Using Near-Infrared Spectroscopy

Adoption of no-till systems in Eastern Washington has been slow due to the difficulty of managing wheat (Triticum aestivum L.) straw residue and the unknown decomposition potential of cultivars. We hypothesize that by analyzing wheat straw with near-infrared spectroscopy (NIRS), calibration models can be developed to accurately predict fiber and chemical constituents of wheat, determining straw decomposition potential. Straw from a panel of 480 soft winter wheat cultivars adapted to the Pacific Northwest are analyzed for neutral detergent fiber (NDF), acid detergent fiber (ADF), acid detergent lignin (ADL), cellulose, hemicellulose, carbon (C), and nitrogen (N). Using modified partial least squares regression and cross validation techniques, specific environment and broad-based NIRS models are calibrated and predictive ability is validated. R2cal values from broad models are better than the specific models, and are 0.85 (NDF), 0.86 (ADF), 0.65 (ADL), 0.88 (cellulose), 0.42 (hemicellulose), 0.67 (C), and 0.73 (N). The corresponding SEP values are 1.68% (NDF), 1.54% (ADF), 0.62% (ADL), 1.14% (cellulose), 1.11% (hemicellulose), 1.23% (C), and 0.06% (N). A Finch &times; Eltan breeding population is used to further validate models and prediction accuracies for variety selection within a breeding program scenario. The broad NIRS models prove useful for estimating high and low ranges of NDF, ADF, and cellulose in wheat cultivars which translate into characteristics of slow and fast decomposition potential

Edoxaban versus warfarin in patients with atrial fibrillation

Contains fulltext : 125374.pdf (publisher's version ) (Open Access)BACKGROUND: Edoxaban is a direct oral factor Xa inhibitor with proven antithrombotic effects. The long-term efficacy and safety of edoxaban as compared with warfarin in patients with atrial fibrillation is not known. METHODS: We conducted a randomized, double-blind, double-dummy trial comparing two once-daily regimens of edoxaban with warfarin in 21,105 patients with moderate-to-high-risk atrial fibrillation (median follow-up, 2.8 years). The primary efficacy end point was stroke or systemic embolism. Each edoxaban regimen was tested for noninferiority to warfarin during the treatment period. The principal safety end point was major bleeding. RESULTS: The annualized rate of the primary end point during treatment was 1.50% with warfarin (median time in the therapeutic range, 68.4%), as compared with 1.18% with high-dose edoxaban (hazard ratio, 0.79; 97.5% confidence interval [CI], 0.63 to 0.99; P<0.001 for noninferiority) and 1.61% with low-dose edoxaban (hazard ratio, 1.07; 97.5% CI, 0.87 to 1.31; P=0.005 for noninferiority). In the intention-to-treat analysis, there was a trend favoring high-dose edoxaban versus warfarin (hazard ratio, 0.87; 97.5% CI, 0.73 to 1.04; P=0.08) and an unfavorable trend with low-dose edoxaban versus warfarin (hazard ratio, 1.13; 97.5% CI, 0.96 to 1.34; P=0.10). The annualized rate of major bleeding was 3.43% with warfarin versus 2.75% with high-dose edoxaban (hazard ratio, 0.80; 95% CI, 0.71 to 0.91; P<0.001) and 1.61% with low-dose edoxaban (hazard ratio, 0.47; 95% CI, 0.41 to 0.55; P<0.001). The corresponding annualized rates of death from cardiovascular causes were 3.17% versus 2.74% (hazard ratio, 0.86; 95% CI, 0.77 to 0.97; P=0.01), and 2.71% (hazard ratio, 0.85; 95% CI, 0.76 to 0.96; P=0.008), and the corresponding rates of the key secondary end point (a composite of stroke, systemic embolism, or death from cardiovascular causes) were 4.43% versus 3.85% (hazard ratio, 0.87; 95% CI, 0.78 to 0.96; P=0.005), and 4.23% (hazard ratio, 0.95; 95% CI, 0.86 to 1.05; P=0.32). CONCLUSIONS: Both once-daily regimens of edoxaban were noninferior to warfarin with respect to the prevention of stroke or systemic embolism and were associated with significantly lower rates of bleeding and death from cardiovascular causes. (Funded by Daiichi Sankyo Pharma Development; ENGAGE AF-TIMI 48 ClinicalTrials.gov number, NCT00781391.)